Great West Life Assurance CO Allogene Therapeutics, Inc. Transaction History
Great West Life Assurance CO
- $69.9 Billion
- Q3 2025
A detailed history of Great West Life Assurance CO transactions in Allogene Therapeutics, Inc. stock. As of the latest transaction made, Great West Life Assurance CO holds 39,730 shares of ALLO stock, worth $48,867. This represents 0.0% of its overall portfolio holdings.
Number of Shares
39,730
Previous 31,211
27.29%
Holding current value
$48,867
Previous $35,000
42.86%
% of portfolio
0.0%
Previous 0.0%
Shares
23 transactions
Others Institutions Holding ALLO
# of Institutions
181Shares Held
138MCall Options Held
76.6KPut Options Held
36.2K-
Tpg Gp A, LLC Fort Worth, TX18.7MShares$23 Million1.5% of portfolio
-
Black Rock Inc. New York, NY16.4MShares$20.2 Million0.0% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il14MShares$17.2 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.02MShares$11.1 Million0.0% of portfolio
-
Primecap Management CO Pasadena, CA7.08MShares$8.71 Million0.01% of portfolio
About Allogene Therapeutics, Inc.
- Ticker ALLO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 143,807,008
- Market Cap $177M
- Description
- Allogene Therapeutics, Inc., a clinical stage immuno-oncology company, develops and commercializes genetically engineered allogeneic T cell therapies for the treatment of cancer. It develops, manufactures, and commercializes UCART19, an allogeneic chimeric antigen receptor (CAR) T cell product candidate for the treatment of pediatric and adult p...